[Archived] Considerations for the New Four-Month Rifapentine-Moxifloxacin Regimen for Drug-Susceptible TB in the U.S.

2-Hour Webinar
Originally aired September 21, 2021

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

This training was jointly provided by the TB Centers of Excellence and the Centers for Disease Control and Prevention. The Rutgers Global Tuberculosis Institute recorded the webinar.

Link to GTBI Website: https://globaltb.njms.rutgers.edu/educationalmaterials/aa/2021f.php

YouTube Link: https://www.youtube.com/watch?v=vOr5-JPVIMQ

*CME and CE units are not being offered for this recording and there is no participant evaluation.